Results 21 to 30 of about 31,959 (340)

Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls

Frontiers in Physiology, 2022
Background: Up to 53% of individuals who had mild COVID-19 experience symptoms for >3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO2peak) as a result of ...
Rhys I. Beaudry, Andrew R. Brotto, Rhea A. Varughese, Stephanie de Waal, Desi P. Fuhr, Ronald W. Damant, Giovanni Ferrara, Grace Y. Lam, Maeve P. Smith, Michael K. Stickland, Michael K. Stickland   +10 more
doaj   +1 more source

HIV infection is associated with reduced pulmonary diffusing capacity. [PDF]

J Acquir Immune Defic Syndr, 2013
Crothers K, McGinnis K, Kleerup E, Wongtrakool C, Hoo GS, Kim J, Sharafkhaneh A, Huang L, Luo Z, Thompson B, Diaz P, Kirk GD, Rom W, Detels R, Kingsley L, Morris A.   +15 more
europepmc   +2 more sources

Inflammation associated with lung function abnormalities in COVID-19 survivors

BMC Pulmonary Medicine, 2023
Background Activation of inflammatory pathways promotes organ dysfunction in COVID-19. Currently, there are reports describing lung function abnormalities in COVID-19 survivors; however, the biological mechanisms remain unknown. The aim of this study was
Roberto Mancilla-Ceballos, Kathryn M. Milne, Jordan A. Guenette, Arturo Cortes-Telles   +3 more
doaj   +1 more source

Epigenome-wide association study on diffusing capacity of the lung

ERJ Open Research, 2021
Background Epigenetics may play an important role in the pathogenesis of lung diseases. However, little is known about the epigenetic factors that influence impaired gas exchange at the lung.
Natalie Terzikhan, Hanfei Xu, Ahmed Edris, Ken R. Bracke, Fien M. Verhamme, Bruno H.C. Stricker, Josée Dupuis, Lies Lahousse, George T. O'Connor, Guy G. Brusselle   +9 more
doaj   +1 more source

Evaluation of the Clinical Application Value of Domestic New-type MeHow MeAir 9000 in Diffusing Capacity of the Lung Tests for Chronic Respiratory Diseases [PDF]

Zhongguo quanke yixue
Background Pulmonary diffusing capacity testing is widely used in clinical practice for assisting in the diagnosis and quantitative evaluation of interstitial lung diseases, differentiating emphysema, and assessing whether other pulmonary diseases are ...
YAO Shihua, HUANG Ruibo, FU Tuping, WU Zhongping, CHEN Shubing, XIE Yanqing, SHEN Beilan, ZHONG Liping, AN Jiaying, WANG Xudong, LIU Wenting, YU Xinxin, ZHENG Jinping, GAO Yi
doaj   +1 more source

Amiodarone-Induced Pulmonary Toxicity - A Frequently Missed Complication. [PDF]

, 2016
IntroductionAmiodarone is often used in the suppression of tachyarrhythmias. One of the more serious adverse effects includes amiodarone pulmonary toxicity (APT).
Dang, Natasha, Datta, Jyoti, Lam, Vinh, Singh, Navneet K, Sweidan, Alexander J   +4 more
core   +2 more sources

Quantitative CT analysis in patients with pulmonary emphysema: is lung function influenced by concomitant unspecific pulmonary fibrosis? [PDF]

, 2019
Purpose: Quantitative analysis of CT scans has proven to be a reproducible technique, which might help to understand the pathophysiology of chronic obstructive pulmonary disease (COPD) and combined pulmonary fibrosis and emphysema.
Doellinger, Felix, Feldhaus, Felix W., Hubner, Ralf-Harto, Kuhnigk, Jan-Martin, Neumann, Konrad, Theilig, Dorothea Cornelia   +5 more
core   +1 more source

Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease [PDF]

, 2015
Interstitial lung disease (ILD) is a hallmark of systemic sclerosis (SSc). Although high-resolution computed tomography (HRCT) is the gold standard to diagnose ILD, recently lung ultrasound (LUS) has emerged in SSc patients as a new promising technique ...
Amoroso, Antonio, Barbano, Biagio, Barilaro, Giuseppe, Gigante, Antonietta, Giovannetti, Antonello, Lucci, Silvio, Quarta, Silvia, Rosato, Edoardo, ROSSI FANELLI, Filippo   +8 more
core   +1 more source

Serum uric acid as a marker of microvascular damage in systemic sclerosis patients [PDF]

, 2016
Background: Microvascular damage of skin and internal organs is a hallmark of systemic sclerosis (SSc). Serum uric acid (UA) represents a marker of inflammation and endothelial dysfunction.
Amoroso, Antonio, Barbano, Biagio, Barilaro, Giuseppe, Cianci, Rosario, Di Mario, Francesca, Gasperini, Maria Ludovica, Gigante, Antonietta, Quarta, Silvia, Romaniello, Antonella, Rosato, Edoardo   +9 more
core   +1 more source

Percutaneous closure of PFO in patients with reduced oxygen saturation at rest and during exercise : short- and long-term results [PDF]

, 2020
Background. A patent foramen ovale (PFO) is a rare cause of hypoxemia and clinical symptoms of dyspnea. Due to a right-to-left shunt, desaturated blood enters the systemic circulation in a subset of patients resulting in dyspnea and a subsequent ...
De Cuyper, Celine, De Pauw, Michel, De Wolf, Daniël, Derom, Eric, Paelinck, Bernard, Pauwels, Tristan, Van Berendoncks, An, Vermeersch, Gaelle, Vermeersch, Paul   +8 more
core   +2 more sources